![](https://splisense.com/wp-content/uploads/2021/04/deoxyribonucleic-acid-3171255_1920-min-1-768x536.jpg)
Press Releases
SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the Treatment of Cystic Fibrosis, at the European Cystic Fibrosis Conference
SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the Treatment of Cystic Fibrosis, at the European Cystic Fibrosis Conference